La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Manganese, monoamine metabolite levels at birth, and child psychomotor development

Identifieur interne : 000275 ( PascalFrancis/Curation ); précédent : 000274; suivant : 000276

Manganese, monoamine metabolite levels at birth, and child psychomotor development

Auteurs : Larissa Takser [France] ; Donna Mergler [Canada] ; Georgette Hellier [France] ; Josiane Sahuquillo [France] ; Guy Huel [France]

Source :

RBID : Pascal:03-0433727

Descripteurs français

English descriptors

Abstract

Several studies have demonstrated neurobehavioral impairment related to manganese (Mn) exposure in the workplace. Exposure to high doses of manganese is associated with irreversible neurodegenerative disorders resembling idiopathic Parkinson disease. Although there is a risk of Mn accumulation in the foetus during pregnancy, little information exists about developmental effects of environmental low-level exposure in human. For this reason, we conducted a prospective epidemiological study in 247 healthy pregnant women and their babies to determine the long-term effect of in utero Mn levels on child's psychomotor development. Concurrently, we examined the relationship between Mn tissue levels at delivery and foetal plasma monoamine metabolites. Of the newborns, 195 were examined at 9 months, 126 at 3 years and 100 at 6 years. At 9 months, the Brunet-Lézine scales were administered. The McCarthy scales of children's abilities were used at 3 and 6 years. After adjustment for potential confounding co-factors (child's gender, mother's educational level), negative relationships were observed between cord blood Mn levels and several psychomotor sub-scales at age of 3 years: attention (partial r = -0.33, P < 0.001), non-verbal memory (partial r = -0.28, P < 0.01 ), and hand skills (partial r = -0.22, P < 0.05), No significant relationships were observed between Mn measures at birth and the general psychomotor indices, Brunet-Lézine developmental quotient (DQ) at 9 months or McCarthy general cognitive index (GCI) at 3 and 6 years. Maternal blood Mn levels were negatively associated with foetal plasma HVA and 5-HIAA concentrations (adjusted for labour duration, child's gender, and smoking during pregnancy), but the adjustment for monoamine levels at birth did not change the association between the Mn levels and the psychomotor scores. These results suggest that environmental Mn exposure in utero could affect early psychomotor development.
pA  
A01 01  1    @0 0161-813X
A03   1    @0 Neurotoxicology : (Park Forest South)
A05       @2 24
A06       @2 4-5
A08 01  1  ENG  @1 Manganese, monoamine metabolite levels at birth, and child psychomotor development
A11 01  1    @1 TAKSER (Larissa)
A11 02  1    @1 MERGLER (Donna)
A11 03  1    @1 HELLIER (Georgette)
A11 04  1    @1 SAHUQUILLO (Josiane)
A11 05  1    @1 HUEL (Guy)
A14 01      @1 Institut National de la Santé et de la Recherche Médicale (INSERM-U472), Recherche en Épidemiologie et en Biostatistique, 16 Avenue Paul-Vaillant Couturier @2 94807 Villejuif @3 FRA @Z 1 aut. @Z 3 aut. @Z 4 aut. @Z 5 aut.
A14 02      @1 CINBIOSE, Université du Québec à Montréal @2 Montréal, Que. @3 CAN @Z 2 aut.
A20       @1 667-674
A21       @1 2003
A23 01      @0 ENG
A43 01      @1 INIST @2 18397 @5 354000112711200200
A44       @0 0000 @1 © 2003 INIST-CNRS. All rights reserved.
A45       @0 1 p.1/4
A47 01  1    @0 03-0433727
A60       @1 P
A61       @0 A
A64 01  1    @0 Neurotoxicology : (Park Forest South)
A66 01      @0 USA
C01 01    ENG  @0 Several studies have demonstrated neurobehavioral impairment related to manganese (Mn) exposure in the workplace. Exposure to high doses of manganese is associated with irreversible neurodegenerative disorders resembling idiopathic Parkinson disease. Although there is a risk of Mn accumulation in the foetus during pregnancy, little information exists about developmental effects of environmental low-level exposure in human. For this reason, we conducted a prospective epidemiological study in 247 healthy pregnant women and their babies to determine the long-term effect of in utero Mn levels on child's psychomotor development. Concurrently, we examined the relationship between Mn tissue levels at delivery and foetal plasma monoamine metabolites. Of the newborns, 195 were examined at 9 months, 126 at 3 years and 100 at 6 years. At 9 months, the Brunet-Lézine scales were administered. The McCarthy scales of children's abilities were used at 3 and 6 years. After adjustment for potential confounding co-factors (child's gender, mother's educational level), negative relationships were observed between cord blood Mn levels and several psychomotor sub-scales at age of 3 years: attention (partial r = -0.33, P < 0.001), non-verbal memory (partial r = -0.28, P < 0.01 ), and hand skills (partial r = -0.22, P < 0.05), No significant relationships were observed between Mn measures at birth and the general psychomotor indices, Brunet-Lézine developmental quotient (DQ) at 9 months or McCarthy general cognitive index (GCI) at 3 and 6 years. Maternal blood Mn levels were negatively associated with foetal plasma HVA and 5-HIAA concentrations (adjusted for labour duration, child's gender, and smoking during pregnancy), but the adjustment for monoamine levels at birth did not change the association between the Mn levels and the psychomotor scores. These results suggest that environmental Mn exposure in utero could affect early psychomotor development.
C02 01  X    @0 002B03L05
C03 01  X  FRE  @0 Manganèse @2 NC @5 01
C03 01  X  ENG  @0 Manganese @2 NC @5 01
C03 01  X  SPA  @0 Manganeso @2 NC @5 01
C03 02  X  FRE  @0 Métal lourd @5 04
C03 02  X  ENG  @0 Heavy metal @5 04
C03 02  X  SPA  @0 Metal pesado @5 04
C03 03  X  FRE  @0 Toxicité @5 07
C03 03  X  ENG  @0 Toxicity @5 07
C03 03  X  SPA  @0 Toxicidad @5 07
C03 04  X  FRE  @0 Dose faible @5 10
C03 04  X  ENG  @0 Low dose @5 10
C03 04  X  SPA  @0 Dosis débil @5 10
C03 05  X  FRE  @0 Gestation @5 11
C03 05  X  ENG  @0 Pregnancy @5 11
C03 05  X  SPA  @0 Gestación @5 11
C03 06  X  FRE  @0 Descendance @5 12
C03 06  X  ENG  @0 Progeny @5 12
C03 06  X  SPA  @0 Descendencia @5 12
C03 07  X  FRE  @0 Homme @5 13
C03 07  X  ENG  @0 Human @5 13
C03 07  X  SPA  @0 Hombre @5 13
C03 08  X  FRE  @0 Développement psychomoteur @5 14
C03 08  X  ENG  @0 Psychomotor development @5 14
C03 08  X  SPA  @0 Desarrollo psicomotor @5 14
C03 09  X  FRE  @0 Enfant @5 15
C03 09  X  ENG  @0 Child @5 15
C03 09  X  SPA  @0 Niño @5 15
C03 10  X  FRE  @0 Dopamine @2 NK @2 FR @5 16
C03 10  X  ENG  @0 Dopamine @2 NK @2 FR @5 16
C03 10  X  SPA  @0 Dopamina @2 NK @2 FR @5 16
C03 11  X  FRE  @0 Sérotonine @2 NK @2 FR @5 17
C03 11  X  ENG  @0 Serotonin @2 NK @2 FR @5 17
C03 11  X  SPA  @0 Serotonina @2 NK @2 FR @5 17
N21       @1 300
N82       @1 PSI

Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:03-0433727

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Manganese, monoamine metabolite levels at birth, and child psychomotor development</title>
<author>
<name sortKey="Takser, Larissa" sort="Takser, Larissa" uniqKey="Takser L" first="Larissa" last="Takser">Larissa Takser</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Institut National de la Santé et de la Recherche Médicale (INSERM-U472), Recherche en Épidemiologie et en Biostatistique, 16 Avenue Paul-Vaillant Couturier</s1>
<s2>94807 Villejuif</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Mergler, Donna" sort="Mergler, Donna" uniqKey="Mergler D" first="Donna" last="Mergler">Donna Mergler</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>CINBIOSE, Université du Québec à Montréal</s1>
<s2>Montréal, Que.</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Hellier, Georgette" sort="Hellier, Georgette" uniqKey="Hellier G" first="Georgette" last="Hellier">Georgette Hellier</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Institut National de la Santé et de la Recherche Médicale (INSERM-U472), Recherche en Épidemiologie et en Biostatistique, 16 Avenue Paul-Vaillant Couturier</s1>
<s2>94807 Villejuif</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Sahuquillo, Josiane" sort="Sahuquillo, Josiane" uniqKey="Sahuquillo J" first="Josiane" last="Sahuquillo">Josiane Sahuquillo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Institut National de la Santé et de la Recherche Médicale (INSERM-U472), Recherche en Épidemiologie et en Biostatistique, 16 Avenue Paul-Vaillant Couturier</s1>
<s2>94807 Villejuif</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Huel, Guy" sort="Huel, Guy" uniqKey="Huel G" first="Guy" last="Huel">Guy Huel</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Institut National de la Santé et de la Recherche Médicale (INSERM-U472), Recherche en Épidemiologie et en Biostatistique, 16 Avenue Paul-Vaillant Couturier</s1>
<s2>94807 Villejuif</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">03-0433727</idno>
<date when="2003">2003</date>
<idno type="stanalyst">PASCAL 03-0433727 INIST</idno>
<idno type="RBID">Pascal:03-0433727</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000A48</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000275</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Manganese, monoamine metabolite levels at birth, and child psychomotor development</title>
<author>
<name sortKey="Takser, Larissa" sort="Takser, Larissa" uniqKey="Takser L" first="Larissa" last="Takser">Larissa Takser</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Institut National de la Santé et de la Recherche Médicale (INSERM-U472), Recherche en Épidemiologie et en Biostatistique, 16 Avenue Paul-Vaillant Couturier</s1>
<s2>94807 Villejuif</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Mergler, Donna" sort="Mergler, Donna" uniqKey="Mergler D" first="Donna" last="Mergler">Donna Mergler</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>CINBIOSE, Université du Québec à Montréal</s1>
<s2>Montréal, Que.</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author>
<name sortKey="Hellier, Georgette" sort="Hellier, Georgette" uniqKey="Hellier G" first="Georgette" last="Hellier">Georgette Hellier</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Institut National de la Santé et de la Recherche Médicale (INSERM-U472), Recherche en Épidemiologie et en Biostatistique, 16 Avenue Paul-Vaillant Couturier</s1>
<s2>94807 Villejuif</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Sahuquillo, Josiane" sort="Sahuquillo, Josiane" uniqKey="Sahuquillo J" first="Josiane" last="Sahuquillo">Josiane Sahuquillo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Institut National de la Santé et de la Recherche Médicale (INSERM-U472), Recherche en Épidemiologie et en Biostatistique, 16 Avenue Paul-Vaillant Couturier</s1>
<s2>94807 Villejuif</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Huel, Guy" sort="Huel, Guy" uniqKey="Huel G" first="Guy" last="Huel">Guy Huel</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Institut National de la Santé et de la Recherche Médicale (INSERM-U472), Recherche en Épidemiologie et en Biostatistique, 16 Avenue Paul-Vaillant Couturier</s1>
<s2>94807 Villejuif</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Neurotoxicology : (Park Forest South)</title>
<title level="j" type="abbreviated">Neurotoxicology : (Park Forest South)</title>
<idno type="ISSN">0161-813X</idno>
<imprint>
<date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Neurotoxicology : (Park Forest South)</title>
<title level="j" type="abbreviated">Neurotoxicology : (Park Forest South)</title>
<idno type="ISSN">0161-813X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Child</term>
<term>Dopamine</term>
<term>Heavy metal</term>
<term>Human</term>
<term>Low dose</term>
<term>Manganese</term>
<term>Pregnancy</term>
<term>Progeny</term>
<term>Psychomotor development</term>
<term>Serotonin</term>
<term>Toxicity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Manganèse</term>
<term>Métal lourd</term>
<term>Toxicité</term>
<term>Dose faible</term>
<term>Gestation</term>
<term>Descendance</term>
<term>Homme</term>
<term>Développement psychomoteur</term>
<term>Enfant</term>
<term>Dopamine</term>
<term>Sérotonine</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Manganèse</term>
<term>Métal lourd</term>
<term>Homme</term>
<term>Enfant</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Several studies have demonstrated neurobehavioral impairment related to manganese (Mn) exposure in the workplace. Exposure to high doses of manganese is associated with irreversible neurodegenerative disorders resembling idiopathic Parkinson disease. Although there is a risk of Mn accumulation in the foetus during pregnancy, little information exists about developmental effects of environmental low-level exposure in human. For this reason, we conducted a prospective epidemiological study in 247 healthy pregnant women and their babies to determine the long-term effect of in utero Mn levels on child's psychomotor development. Concurrently, we examined the relationship between Mn tissue levels at delivery and foetal plasma monoamine metabolites. Of the newborns, 195 were examined at 9 months, 126 at 3 years and 100 at 6 years. At 9 months, the Brunet-Lézine scales were administered. The McCarthy scales of children's abilities were used at 3 and 6 years. After adjustment for potential confounding co-factors (child's gender, mother's educational level), negative relationships were observed between cord blood Mn levels and several psychomotor sub-scales at age of 3 years: attention (partial r = -0.33, P < 0.001), non-verbal memory (partial r = -0.28, P < 0.01 ), and hand skills (partial r = -0.22, P < 0.05), No significant relationships were observed between Mn measures at birth and the general psychomotor indices, Brunet-Lézine developmental quotient (DQ) at 9 months or McCarthy general cognitive index (GCI) at 3 and 6 years. Maternal blood Mn levels were negatively associated with foetal plasma HVA and 5-HIAA concentrations (adjusted for labour duration, child's gender, and smoking during pregnancy), but the adjustment for monoamine levels at birth did not change the association between the Mn levels and the psychomotor scores. These results suggest that environmental Mn exposure in utero could affect early psychomotor development.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0161-813X</s0>
</fA01>
<fA03 i2="1">
<s0>Neurotoxicology : (Park Forest South)</s0>
</fA03>
<fA05>
<s2>24</s2>
</fA05>
<fA06>
<s2>4-5</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Manganese, monoamine metabolite levels at birth, and child psychomotor development</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>TAKSER (Larissa)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>MERGLER (Donna)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>HELLIER (Georgette)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>SAHUQUILLO (Josiane)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>HUEL (Guy)</s1>
</fA11>
<fA14 i1="01">
<s1>Institut National de la Santé et de la Recherche Médicale (INSERM-U472), Recherche en Épidemiologie et en Biostatistique, 16 Avenue Paul-Vaillant Couturier</s1>
<s2>94807 Villejuif</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>CINBIOSE, Université du Québec à Montréal</s1>
<s2>Montréal, Que.</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA20>
<s1>667-674</s1>
</fA20>
<fA21>
<s1>2003</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>18397</s2>
<s5>354000112711200200</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>1 p.1/4</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>03-0433727</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Neurotoxicology : (Park Forest South)</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Several studies have demonstrated neurobehavioral impairment related to manganese (Mn) exposure in the workplace. Exposure to high doses of manganese is associated with irreversible neurodegenerative disorders resembling idiopathic Parkinson disease. Although there is a risk of Mn accumulation in the foetus during pregnancy, little information exists about developmental effects of environmental low-level exposure in human. For this reason, we conducted a prospective epidemiological study in 247 healthy pregnant women and their babies to determine the long-term effect of in utero Mn levels on child's psychomotor development. Concurrently, we examined the relationship between Mn tissue levels at delivery and foetal plasma monoamine metabolites. Of the newborns, 195 were examined at 9 months, 126 at 3 years and 100 at 6 years. At 9 months, the Brunet-Lézine scales were administered. The McCarthy scales of children's abilities were used at 3 and 6 years. After adjustment for potential confounding co-factors (child's gender, mother's educational level), negative relationships were observed between cord blood Mn levels and several psychomotor sub-scales at age of 3 years: attention (partial r = -0.33, P < 0.001), non-verbal memory (partial r = -0.28, P < 0.01 ), and hand skills (partial r = -0.22, P < 0.05), No significant relationships were observed between Mn measures at birth and the general psychomotor indices, Brunet-Lézine developmental quotient (DQ) at 9 months or McCarthy general cognitive index (GCI) at 3 and 6 years. Maternal blood Mn levels were negatively associated with foetal plasma HVA and 5-HIAA concentrations (adjusted for labour duration, child's gender, and smoking during pregnancy), but the adjustment for monoamine levels at birth did not change the association between the Mn levels and the psychomotor scores. These results suggest that environmental Mn exposure in utero could affect early psychomotor development.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B03L05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Manganèse</s0>
<s2>NC</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Manganese</s0>
<s2>NC</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Manganeso</s0>
<s2>NC</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Métal lourd</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Heavy metal</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Metal pesado</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Toxicité</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Toxicity</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Toxicidad</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Dose faible</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Low dose</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Dosis débil</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Gestation</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Pregnancy</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Gestación</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Descendance</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Progeny</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Descendencia</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Homme</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Human</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Développement psychomoteur</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Psychomotor development</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Desarrollo psicomotor</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Enfant</s0>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Child</s0>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Niño</s0>
<s5>15</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Dopamina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>16</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Sérotonine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Serotonin</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Serotonina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>17</s5>
</fC03>
<fN21>
<s1>300</s1>
</fN21>
<fN82>
<s1>PSI</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000275 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000275 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:03-0433727
   |texte=   Manganese, monoamine metabolite levels at birth, and child psychomotor development
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022